Endometriosis-associated infertility: options of combined therapy

In: Voprosy ginekologii, akušerstva i perinatologii · 2020 · vol. 19(2) , pp. 27–34 · doi:10.20953/1726-1678-2020-2-27-34 · W3032269312
article OA: closed CC0 ⤵ 1 in-corpus citation
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06+body, 2026-06-12

This study evaluated didrogesterone combined with surgery for endometriosis-associated infertility, finding a 1.6 times higher pregnancy rate and 2.4 times higher chance of successful infertility management.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-12 · read from full text

This paper evaluated the effectiveness of adding didrogesterone to surgical treatment for infertility in women with a verified diagnosis of ovarian endometriosis. In 75 included participants, 36 received only surgery and 39 received surgery plus didrogesterone 10 mg/day from cycle day 14 to 25 for 6 months, with outcomes assessed by clinical pregnancy incidence over 12 months and pregnancy outcomes. Clinical pregnancy incidence was higher with combined therapy (69.2% vs 44.4%, p=0.03), and live birth percentages among pregnancies were also higher; overall chances of successful infertility management were reported as 59.0% vs 25.0% (p=0.0029). This paper centrally about endometriosis — it tests didrogesterone as post-operative and pregravid preparation in endometriosis-associated infertility.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 2,392 characters · extracted from oa-doi-fallback · click to expand
Endometriosis-associated infertility: options of combined therapy Mekan R.Orazov / V.Е.Radzinskiy / Marina B. Khamoshina / Lyudmila V. Mikhaleva / А.О.Dukhin / Snezhana V. Volkova / V.B.Shustova / М.Z.Аbitova / Objective. To evaluate the effectiveness of using didrogesterone in combined therapy of endometriosis-associated. Patients and methods. The study included patients with infertility and verified diagnosis of ovarian endometriosis. The screening involved 108 women, of them 75 corresponded to the inclusion criteria. They were divided into two statistically comparable groups depending on a therapy option aimed at management of infertility. Group 1 (n = 36) included patients who underwent only surgical treatment, group 2 (n = 39) – women, who received combined therapy (surgical treatment + didrogesterone 10 mg/day from the 14th to the 25th day of the menstrual cycle for 6 months). The effectiveness of treatment was assessed by the incidence of clinical pregnancy within a 12-month follow-up period and, in case of pregnancy occurrence, by its outcomes. Results. As has been found, pregnancy incidence in women who received combined therapy exceeds by 1.6 times the results in the group of patients who underwent only surgical: 69.2 vs. 44.4%, p = 0.03. In combined treatment with the use of didrogesterone in the second phase of the cycle, the percentage of live births from the total number of pregnancies was significantly higher (by 1.3 times) as compared with group 1, and taking into consideration a greater incidence of pregnancy, the chances of successful management of infertility were by 2.4 times higher with inclusion of didrogesterone in therapy: 59.0% (23 of 39) in group 2 and only 25.0% (9 of 36) in group 1 (p = 0.0029). Conclusion. The use of didrogesterone as post-operative therapy and pregravid preparation of patients with endometriosisassociated infertility significantly improves the effectiveness of treatment and reproductive outcomes. Key words: infertility, didrogesterone, drug therapy, surgical treatment, ovarian endometriosis. For citation: Orazov M.R., Radzinskiy V.Е., Khamoshina M.B., Mikhaleva L.M., Dukhin А.О., Volkova S.V., Shustova V.B., Аbitova М.Z. Endometriosisassociated infertility: options of combined therapy. Vopr. ginekol. akus. perinatol. (Gynecology, Obstetrics and Perinatology). 2020; 19(2): 27–34. (In Russian). Open access

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK